Move Your Oncology Research Forward
At Catalyst Oncology, we’re committed to advancing the field of oncology research. With our extensive experience and expertise, we offer tailored solutions across all phases of oncology studies. Our deep understanding of the nuances within oncology, from early- to late– phase trials, ensures that your research is in the hands of experts every step of the way.
Early Phase Research
Catalyst Oncology specializes in the intricacies of first-in-human (FIH), Phase I, and Phase II cancer studies working with world– leading cancer centers.
Late Phase Research
We are able to seamlessly move forward Phase II and Phase III studies across the globe with our network of skilled clinical trial professionals and patient recruitment experts.
With our exclusive biotech focus and next-gen and novel oncology experience, Catalyst Oncology supports early- to late-phase drug development across a range of both solid and hematologic indications.
Advance Your Next-generation Cancer Therapy
Catalyst Oncology is a specialty oncology contract research organization with expertise across all drug development phases. We devote time, energy, and capital to supporting biotechs in bringing next-generation cancer therapies.
Progress Your Research with Catalyst Oncology
Let’s embark on this oncology research journey together. Learn more about how we can provide exceptional CRO and consulting support and services for your clinical studies.